# Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas

> **NCT00929669** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 2 (actual)

## Conditions studied

- Gonadotroph Adenomas

## Interventions

- **DRUG:** pasireotide LAR

## Key facts

- **NCT ID:** NCT00929669
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** unable to identify a third subject
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929669, "Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00929669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*